Shreekrishna Biotech (Delisted) share price

BSE: 505592Commercial Services & Supplies

Shreekrishna Biotech Ltd. · Face value ₹10 · Listed Nov 1983

Last traded ₹141.40 on 12 Aug 2015

Delisted on 23 Nov 2023.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

  1. Jul 2019

    • 18 Jul · Shareholding for the Period Ended June 30, 2019

      Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....
  2. Apr 2019

    • 17 Apr · Shareholding for the Period Ended March 31, 2019

      Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....
  3. Jan 2019

    • 19 Jan · Shareholding for the Period Ended December 31, 2018

      Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....
    • 9 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
  4. Oct 2018

    • 17 Oct · Shareholding for the Period Ended September 30, 2018

      Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....
    • 16 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0

Share price history

Daily closes since Nov 2012, adjusted for splits and bonuses

Daily close, ₹ per share

Q1 results, quarter to Jun 2018

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.00 Cr
Operating profit
₹0.00 Cr
Net profit
₹0.00 Cr
Earnings per share
₹0.00

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income0.0
  7. Finance costs0.0
  8. Profit before tax0.0
  9. Tax0.0
  10. Net profit0.0

Shreekrishna Biotech results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2018. Results for the quarter to Sep 2018 were due by 14 Nov 2018, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
0.0Sep 150.0Dec 15Mar 160.0Jun 160.0Sep 160.0Dec 160.0Mar 170.0Jun 170.0Sep 170.0Dec 17Mar 1800.0Jun 18
A loss in 10 of the 10 quarters with results on record

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Q1
Revenue from operations0.010.010.01––––––––––––––––0.00
–––––––––––––––––––0.00
Materials and goods bought–––––––––––––––––––0.00
Employee costs–––––––––––––––––––0.00
Other expenses–––––––––––––––––––0.00
Operating profit before depreciation–––––––––––––––––––0.00
Depreciation and amortisation–––––––––––––––––––0.00
Other income–––––––––––––––––––0.00
Finance costs–––––––––––––––––––0.00
One-off items–––––––––––––––––––0.00
Profit before tax0.000.00−0.010.000.000.000.000.000.000.00–0.00−0.010.00−0.010.000.000.00–0.00
Tax–––––––––––––––––––0.00
Net profit0.000.00−0.010.000.000.000.000.000.000.00–0.00−0.010.00−0.010.000.000.00–0.00
Net margin12.5%12.5%−120.0%–––––––––––––––––
Earnings per share₹2.13₹2.13−₹0.01₹0.00––––––––––−₹0.01––––₹0.00
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarters to Mar 2016 and Mar 2018.

9 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
0.00.0Mar 090.00.0Mar 100.00.0Mar 110.00.0Mar 12Mar 130.00.0Mar 140.0Mar 150.0Mar 160.0Mar 17
Peak revenue ₹0.03 Cr, year to Mar 2014; lowest ₹0.02 Cr, year to Mar 2010A loss in 4 of the 8 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin
5.9%−17.9%4.5%5.9%5.6%5.0%−17.9%Mar 09Mar 11Mar 13Mar 15Mar 17

Results for the year to Mar 2017

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Profit before tax0.0
  2. Net profit0.0

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2013.

₹ croreMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue from operations0.020.020.020.02–0.03–––
Depreciation and amortisation0.000.000.000.00–––––
Profit before tax0.000.000.000.00–−0.01−0.010.00−0.02
Tax–0.000.000.00–––––
Net profit0.000.000.000.00–−0.01−0.010.00−0.02
Net margin4.5%5.9%5.6%5.0%–−17.9%–––
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2009, Mar 2010, Mar 2011 and Mar 2012: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2014: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2015, Mar 2016 and Mar 2017: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2014Mar 2015Mar 2016Mar 2017
Earnings per share₹0.00––−₹0.02
Diluted earnings per share₹0.00––−₹0.02

Ratios

Standalone, years to March.

RatioMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue growth−22.7%5.9%11.1%–––––
Net profit growth0.0%0.0%0.0%–––––

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Effective tax ratePublished threshold 17.16 per cent100.0050.0050.00–––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Shreekrishna Biotech share price by year

Each calendar year to 2015.

YearClose at year endChangeHighest closeLowest close
2015141.40−53.5%289.10141.40
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 12 Aug 2015.

Recent sessions

The 10 trading days to 12 Aug 2015, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
12 Aug 2015141.40141.40141.40141.40141.401
3 Aug 2015148.80148.80148.80148.80148.8025
21 Jul 2015156.60156.60156.60156.60156.601
3 Jul 2015164.80164.80164.80164.80164.801
11 Jun 2015173.40173.40173.40173.40173.40700
28 Feb 2015182.50182.50182.50182.50182.5070
20 Feb 2015192.10192.10192.10192.10192.1025
10 Feb 2015202.20202.20202.20202.20202.2025
2 Feb 2015212.80212.80212.80212.80212.8046
27 Jan 2015223.90223.90223.90223.90223.905
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
505592
ISIN
INE571N01015
Industry
Commercial Services & Supplies
CIN
L99999MH1983PLC029347
Corporate identity number, the registrar of companies' code for it
Incorporated
1983
Registered office
B - 17 & 18, OM Swati Manor CHS. Ltd, 2nd Floor, N C Kelkar Road, Near Plaza Cinema, Dadar, Mumbai 400028, Maharashtra
Share registrar
Purva Sharegistry (India) Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments